M3, Inc.
Stock Price Chart
2026/06/15 UpdatedPrice Trend
2026/06/15 UpdatedPrice & Trading Details
2026/06/15 UpdatedPRICE
TRADING
Analyst Recommendations 13 analysts
Updated 2026/06/05Shareholder Composition
Updated 2026/06/05Top Mutual Funds / ETFs
Updated 2026/06/05Major Holders
Updated 2026/06/05| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
MFS SERIES TRUST X-MFS International Intrinsic Value Fund
|
11.5M | -1.62% | |
|
HARDING LOEVNER Fd.S INC-Harding Loevner Intl Eqy. PORT.
|
7.4M | -10.61% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
6.0M | +0.89% | |
|
John Hancock Funds III-International Growth Fund
|
5.0M | 0.00% | |
|
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund
|
4.5M | +1.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
3.9M | +1.99% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
3.6K | +1.52% |
Dividend History 1Years Growth
Updated 2026/06/14| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥22 | +4.8% |
| 2025 | ¥21 | 0.0% |
| 2024 | ¥21 | +10.5% |
| 2023 | ¥19 | +18.8% |
| 2022 | ¥16 | - |
Financial Performance
2026/06/14 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥208,159M | ¥230,818M | ¥238,883M | ¥284,900M |
| Gross Profit | ¥123,268M | ¥135,186M | ¥140,531M | ¥154,364M |
| Operating Income | ¥66,222M | ¥70,511M | ¥63,024M | ¥60,299M |
| Pretax Income | ¥96,239M | ¥74,387M | ¥69,231M | ¥65,502M |
| Net Income | ¥63,845M | ¥49,028M | ¥45,271M | ¥40,484M |
| EPS | ¥93.98 | ¥72.17 | ¥66.63 | ¥59.60 |
| Operating Margin | 31.81% | 30.55% | 26.38% | 21.16% |
| Balance Sheet | ||||
| Total Assets | ¥345,981M | ¥400,645M | ¥490,780M | ¥581,741M |
| Total Equity | ¥257,840M | ¥302,630M | ¥351,915M | ¥378,436M |
| Total Liabilities | ¥88,141M | ¥98,015M | ¥138,865M | ¥203,305M |
| Cash | ¥104,253M | ¥118,319M | ¥149,661M | ¥134,933M |
| Interest-bearing Debt | - | ¥111M | ¥18,514M | ¥24,420M |
| Equity Ratio | 74.52% | 75.54% | 71.71% | 65.05% |
| D/E Ratio | 0.00 | 0.00 | 0.05 | 0.06 |
| Cash Flow | ||||
| Operating CF | ¥52,108M | ¥57,113M | ¥58,310M | ¥51,743M |
| Investing CF | -¥23,407M | -¥21,933M | -¥39,456M | -¥39,149M |
| Financing CF | -¥16,371M | -¥22,837M | ¥9,432M | -¥27,165M |
| Free CF | ¥48,891M | ¥51,759M | ¥50,729M | ¥42,752M |
| Efficiency | ||||
| ROE | 24.76% | 16.20% | 12.86% | 10.70% |
| ROA | 18.45% | 12.24% | 9.22% | 6.96% |
Latest IR Information
-
[Ellemsree] Fiscal Year Ending March 2026 Financial Results | Revenue Unavailable (YoY Unavailable)
Ellemsree's fiscal year ending March 2026 financial results have been announced, but details on revenue and profits are unavailable. The parent company owns 34.5% of Sony Group, with no operational dependence or significant transactions.
Read more -
Wholesman Full Subsidiary Acquisition and New Business Development|June 2026
M3 has acquired all shares of Wholesman and completed the full subsidiary acquisition. Through the establishment of a foundation for new businesses and promoting DX, the company aims to improve efficiency and expand the medical and nursing care markets.
Read more -
[M Three] Announcing Acquisition of Subsidiary in Healthcare and Nursing Care Fields | June 2026
M Three has made WiseMan of Iwate Prefecture a consolidated subsidiary, strengthening support for ICTization in healthcare and nursing care. The acquisition aims to expand the business foundation and promote DX.
Read more -
【M3】Share Buyback Status|May 2026
M3 resolved to acquire shares through a share buyback at the Board of Directors meeting held on May 1, 2026, but as of May 31, 2026, no shares had been acquired.
Read more -
Notice Regarding Resolution on Share Buyback (Acquisition of Treasury Stock Based on the Provisions of Article 459, Paragraph 1 of the Companies Act)
m3, Inc. has resolved to acquire up to 20,000,000 shares of treasury stock, with a maximum purchase value of 20 billion yen, from May 2, 2026, to April 30, 2027.
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥2,245
Rating Score: 1.75 (Based on 13 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
M3, Inc. provides medical-related services to physicians and other healthcare professionals through the internet. It operates m3.com, a members-only website for providing information, tools, and services for medical professionals; MR-kun which delivers the latest medical information for daily medical practice; QOL-kun, a marketing support service that provides selected information useful for doctors; m3.com CAREER, a physician recruitment and career change support site; and Drug Carrier, a job information site for pharmacists. The company also provides online lectures; clinical trial; research targeting domestic medical professionals; medical-related self-planned data and research reports; global health professional research; survey panel provision services; and m3.com opening and management services. In addition, it offers AskDoctors, where registered doctors answer questions about health and illness from the public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides services for pharmaceutical companies; and drug information database. Further, the company is involved in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; Support for recruiting subjects necessary for clinical development and clinical research, and related tasks; provision of management support to medical institutions, as well as visiting nursing, day care, and home care support services; and operates podiatry and venous disease clinics, and hospice facilities. Additionally, it offers clinical and medico-political news and education for medical professionals. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.